Kindred Healthcare, Inc. (NYSE:KND) posted its earnings results on Monday. The health services provider reported ($0.11) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.19) by $0.08, Bloomberg Earnings reports. The company had revenue of $1.48 billion for the quarter, compared to analysts’ expectations of $1.44 billion. Kindred Healthcare had a positive return on equity of 3.49% and a negative net margin of 16.31%. The firm’s quarterly revenue was down 5.5% compared to the same quarter last year. During the same period last year, the business posted $0.05 earnings per share. Kindred Healthcare updated its FY18 guidance to $0.65-$0.85 EPS.

Kindred Healthcare (NYSE KND) traded up $0.10 during trading hours on Tuesday, reaching $6.00. The company had a trading volume of 1,937,209 shares, compared to its average volume of 1,090,000. The firm has a market capitalization of $522.11, a price-to-earnings ratio of 16.39 and a beta of 1.11. Kindred Healthcare has a 1 year low of $5.50 and a 1 year high of $11.90. The company has a current ratio of 1.51, a quick ratio of 1.49 and a debt-to-equity ratio of 5.36.

ILLEGAL ACTIVITY WARNING: This news story was first posted by Watch List News and is the property of of Watch List News. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The legal version of this news story can be read at https://www.watchlistnews.com/kindred-healthcare-inc-knd-issues-earnings-results/1686015.html.

A number of research firms have issued reports on KND. BidaskClub cut Kindred Healthcare from a “sell” rating to a “strong sell” rating in a research note on Tuesday, August 8th. Zacks Investment Research upgraded Kindred Healthcare from a “sell” rating to a “hold” rating in a research note on Friday, August 11th. Bank of America Corporation cut their target price on Kindred Healthcare from $7.50 to $6.50 and set an “underperform” rating on the stock in a research note on Thursday, September 21st. Mizuho reissued a “neutral” rating and set a $7.50 price target (down from $8.00) on shares of Kindred Healthcare in a report on Tuesday, October 10th. Finally, Royal Bank Of Canada lowered their price target on Kindred Healthcare from $9.00 to $7.50 and set a “sector perform” rating on the stock in a report on Thursday, September 21st. Six equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and one has assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $8.75.

Kindred Healthcare Company Profile

Kindred Healthcare, Inc, incorporated on March 27, 1998, is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.

Earnings History for Kindred Healthcare (NYSE:KND)

Receive News & Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.